Clinical findings when erythrocytosis was detected.
| Characteristic | Overall (N=330) | PV (N=61) | OSA (N=96) | CLD (N=31) | |
|---|---|---|---|---|---|
| Weight loss | 35 (11%) | 16 (26%) | 6 (6.2%) | 4 (13%) | 0.002 |
| Fatigue | 111 (34%) | 18 (30%) | 41 (43%) | 10 (32%) | 0.2 |
| Vasomotor symptoms | 132 (40%) | 32 (52%) | 46 (48%) | 11 (35%) | 0.3 |
| Dyspnea | 75 (23%) | 3 (4.9%) | 29 (30%) | 16 (52%) | <0.001 |
| Snoring | 133 (40%) | 4 (6.6%) | 75 (78%) | 7 (23%) | <0.001 |
| Palpable splenomegaly | 54 (16%) | 28 (46%) | 13 (14%) | 0 (0%) | <0.001 |
| Palpable hepatomegaly | 31 (9.4%) | 15 (25%) | 7 (7.3%) | 0 (0%) | <0.001 |
| Arterial thrombosis | 25 (7.6%) | 5 (8.2%) | 2 (2.1%) | 1 (3.2%) | 0.2 |
| Venous thrombosis | 31 (9.4%) | 13 (21%) | 5 (5.2%) | 4 (13%) | 0.007 |
Summaries presented in N (%).
Abbreviations: CLD, chronic lung disease; OSA, obstructive sleep apnea; PV, polycythemia vera.
Blood Res 2021;56:166~174 https://doi.org/10.5045/br.2021.2021111
© Blood Research
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd